Business Context and Reporting Period
This Form 8-K was filed by Sonim Technologies, Inc. (not DNA X, Inc.) on February 18, 2022, reporting an event that occurred on February 16, 2022. The company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol "SONM".
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a regulatory listing deficiency regarding the company's stock price.
Material Changes
The primary material event is the receipt of a deficiency letter from Nasdaq. The company's common stock closing bid price remained below the required $1.00 per share for 30 consecutive business days, violating Nasdaq Listing Rule 5450(a)(1).
Guidance, Outlook, and Risks
- Compliance Period: The company has 180 calendar days (until August 15, 2022) to regain compliance.
- Remediation Requirements: To comply, the stock must close at or above $1.00 per share for 10 consecutive trading days within the compliance period.
- Management Action: The company is evaluating options to regain compliance, including a potential reverse stock split.
- Risks: If compliance is not achieved, the company may face delisting. While a second 180-day period may be available if other listing standards are met, there is no assurance the company will successfully cure the deficiency or avoid delisting.
Investor Verification Checklist
- Verify the current trading price of SONM to assess proximity to the $1.00 threshold.
- Monitor for announcements regarding a reverse stock split or other capital structure changes.
- Check for any subsequent correspondence from Nasdaq regarding the extension of the compliance period or delisting notices.
- Review the company's most recent 10-K or 10-Q for underlying financial performance metrics not included in this 8-K.